Cardiac Abnormalities in Type 1 Facioscapulohumeral Muscular Dystrophy

J Clin Neuromuscul Dis. 2017 Jun;18(4):199-206. doi: 10.1097/CND.0000000000000144.

Abstract

Objectives: We conducted a retrospective study to characterize the cardiac complications in patients with genetically confirmed type 1 facioscapulohumeral dystrophy.

Methods: We reviewed baseline cardiac investigations, including electrocardiogram, Holter electrocardiogram and echocardiogram, as well as cardiac complications that occurred during follow-up in 56 adult patients (37 men, mean duration of disease: 20 years).

Results: Baseline evaluation revealed minor cardiac anomalies in 23 patients including incomplete right bundle branch block (iRBBB) in 13 patients (23%). Over a mean follow-up period of 7.2 years, there was no cardiac death, no patient developed cardiomyopathy, and 28 patients (50%) experienced cardiac anomalies. Among these patients, 3 had one or more major events (heart failure and/or atrial fibrillation). The remaining 25 patients presented minor cardiac anomalies of which iRBBB was the most frequent (25%).

Conclusions: Cardiac anomalies identified during the follow-up of patients with type 1 facioscapulohumeral dystrophy are mainly minor anomalies, dominated by the iRBBB.

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Electrocardiography
  • Female
  • Forced Expiratory Volume / physiology
  • Heart Diseases / diagnosis*
  • Heart Diseases / etiology*
  • Humans
  • Longitudinal Studies
  • Male
  • Microfilament Proteins
  • Middle Aged
  • Muscular Dystrophy, Facioscapulohumeral / complications*
  • Muscular Dystrophy, Facioscapulohumeral / genetics
  • Nuclear Proteins / genetics
  • RNA-Binding Proteins
  • Retrospective Studies
  • Risk Factors
  • Vital Capacity / physiology
  • Young Adult

Substances

  • FRG1 protein, human
  • Microfilament Proteins
  • Nuclear Proteins
  • RNA-Binding Proteins